ScoreWhy is Fortress Biotech, Inc. ?
1
With a growth in Net Sales of 1.41%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 152.08 MM
- ROCE(HY) Highest at 138.54%
- RAW MATERIAL COST(Y) Fallen by 1.59% (YoY)
2
With ROE of -101.83%, it has a attractive valuation with a 1.53 Price to Book Value
- Over the past year, while the stock has generated a return of 65.19%, its profits have risen by 50.1%
3
High Institutional Holdings at 31.8%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 3.65% over the previous quarter.
4
Market Beating Performance
- The stock has generated a return of 65.19% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Fortress Biotech, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fortress Biotech, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fortress Biotech, Inc.
65.19%
0.66
79.55%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.71%
EBIT Growth (5y)
1.56%
EBIT to Interest (avg)
-10.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
0.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
31.80%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.53
EV to EBIT
-0.59
EV to EBITDA
-0.64
EV to Capital Employed
2.18
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-369.24%
ROE (Latest)
-101.83%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend28What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 152.08 MM
ROCE(HY)
Highest at 138.54%
RAW MATERIAL COST(Y)
Fallen by 1.59% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -124.66 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.48 times
PRE-TAX PROFIT(Q)
Highest at USD 149.38 MM
NET PROFIT(Q)
Highest at USD 117.2 MM
EPS(Q)
Highest at USD 2.82
-4What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.02 times
INTEREST(Q)
Highest at USD 3.37 MM
Here's what is working for Fortress Biotech, Inc.
Pre-Tax Profit
At USD 149.38 MM has Grown at 1,334.35%
over average net sales of the previous four periods of USD -12.1 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 117.2 MM has Grown at 6,044.03%
over average net sales of the previous four periods of USD -1.97 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 152.08 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
Highest at USD 149.38 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 117.2 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 2.82
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -124.66 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.48 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 1.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 1.7 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Fortress Biotech, Inc.
Interest
At USD 3.37 MM has Grown at 65.02%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 3.37 MM
in the last five periods and Increased by 65.02% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debtors Turnover Ratio
Lowest at 3.02 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
